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Abstract 
Background: Malaria in pregnancy has devastating consequences for both the expectant mother and baby. Annu-
ally, 88.2 (70%) of the 125.2 million pregnancies in malaria endemic regions occur in the Asia–Pacific region. The con-
trol of malaria in pregnancy in most of Asia relies on passive case detection and prevention with long-lasting insec-
ticide-treated nets. Indonesia was the first country in the region to introduce, in 2012, malaria screening at pregnant 
women’s first antenatal care visit to reduce the burden of malaria in pregnancy. The study assessed health providers’ 
acceptability and perceptions on the feasibility of implementing the single screening and treatment (SST) strategy in 
the context of the national programme in two endemic provinces of Indonesia.
Methods: Qualitative data were collected through in-depth interviews with 86 health providers working in provision of 
antenatal care (midwives, doctors, laboratory staff, pharmacists, and heads of drug stores), heads of health facilities and 
District Health Office staff in West Sumba and Mimika districts in East Nusa Tenggara and Papua provinces, respectively.
Results: Health providers of all cadres were accepting of SST as a preventive strategy, showing a strong preference 
for microscopy over rapid diagnostic tests (RDTs) as the method of screening. Implementation of the policy was 
inconsistent in both sites, with least extensive implementation reported in West Sumba compared to Mimika. SST 
was predominantly implemented at health centre level using microscopy, whereas implementation at community 
health posts was said to occur in less than half the selected health facilities. Lack of availability of RDTs was cited as the 
major factor that prevented provision of SST at health posts, however as village midwives cannot prescribe medicines 
women who test positive are referred to health centres for anti-malarials. Few midwives had received formal training 
on SST or related topics.
Conclusions: The study findings indicate that SST was an acceptable strategy among health providers, however imple-
mentation was inconsistent with variation across different localities within the same district, across levels of facility, and 
across different cadres within the same health facility. Implementation should be re-invigorated through reorientation 
and training of health providers, stable supplies of more sensitive RDTs, and improved data capture and reporting.
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Antimalarials, Dihydroartemisinin–piperaquine
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Open Access
Malaria Journal
*Correspondence:  jenny.hill@lstmed.ac.uk 
1 Department of Clinical Sciences, Liverpool School of Tropical Medicine, 
Liverpool, UK
Full list of author information is available at the end of the article
Page 2 of 12Hill et al. Malar J  (2018) 17:309 
Background
Malaria in pregnancy has adverse and often severe con-
sequences for both mother and baby. An estimated 88.2 
of 125.2 million pregnancies (70%) in malaria endemic 
regions occur in the Asia–Pacific region each year, of 
which 6.4 million pregnancies occur in Indonesia [1]. 
Indonesia has one of the most diverse malaria epidemiol-
ogy’s globally. Of the 4.4 million pregnancies estimated to 
occur in areas with Plasmodium falciparum transmission 
nationally, 2 million are in areas with stable transmission 
and 2.4 million in areas with unstable transmission [1]. 
An estimated 6.3 million pregnancies occur in areas with 
Plasmodium vivax transmission and 4.3 million in areas 
in which P. falciparum and P. vivax coexist [1]. Both P. fal-
ciparum and P. vivax infections are associated with severe 
maternal anaemia, fetal loss and reduction in mean birth 
weight or low birth weight [2, 3]. Although the annual 
parasite incidence in Indonesia has fallen dramatically 
over the past 10 years, from 2.89 to 0.9 per 1000, and up 
to 72% of its population live in malaria free areas [4], the 
prevalence of malarial infection as determined by micros-
copy in some regions in Indonesia and Papua New Guinea 
is as high as 10–20% [5]. The harmful effects of malaria 
in pregnancy are preventable yet the Asia–Pacific region 
has no regional prevention strategy, with World Health 
Organization (WHO) recommendations relying on pas-
sive case detection and case management alongside the 
use of long-lasting insecticide-treated nets (LLINs) [6, 7].
Indonesia was the first country in the Asia region to 
have developed a national screening policy for preven-
tion of malaria in pregnancy. First introduced in 2012, 
the policy consists of screening all pregnant women 
at first antenatal care (ANC) visit with either micros-
copy or a rapid diagnostic test (RDT) and treatment of 
parasite positive cases with the national recommended 
anti-malarial [8]. At the time of the study, quinine was 
recommended for treatment of malaria in the first tri-
mester and dihydroartemisinin–piperaquine (DP) in 
the second and third trimesters [9]. The concept of the 
single screening and treatment (SST) policy is that the 
detection and treatment of malaria infections early in 
pregnancy will reduce the harmful effects to the growing 
fetus. On subsequent ANC visits, only women who have 
symptoms of suspected malaria, such as fever, are tested 
for malaria and positive cases are treated with either qui-
nine or DP depending on the trimester of pregnancy.
An evaluation of the SST policy in Indonesia was 
undertaken to assess the acceptability and effectiveness 
of health providers in delivering SST to pregnant women 
through antenatal clinics in the routine health system set-
ting. The findings from the qualitative study on accept-
ability and the perceptions of health providers on the 
feasibility of implementation of SST are presented here. 
The results from the quantitative study measuring effec-
tiveness of antenatal clinics to deliver SST are published 
separately (Webster et al. [10]).
Methods
Study site and context
The study was conducted between February and July 
2015 in two districts in two island provinces of Eastern 
Indonesia, West Sumba District in East Nusa Tenggara 
Province, and Mimika District in Papua Province. Papua 
Province has the highest burden of malaria in Indonesia, 
defined as moderate year-round transmission. Malaria 
transmission in West Sumba is low and focal or local-
ized, and is the district with the lowest number of malaria 
cases in Sumba island [11, 12]. The study was nested in 
a clinical trial on alternative prevention strategies (Trial 
registration number ISRCTN 34010937) that was under-
taken by the same research group in the same district in 
Papua and in an adjacent district in Sumba for conveni-
ence of logistics and availability of field staff (Ahmed 
et al. pers. comm.).
Mimika District lies in the south of Papua Province, 
covering 19,959  square kilometres consisting of high-
lands and lowlands. It has a rapidly growing population 
of an estimated 182,000 (2010 census [13]) Papuan and 
non-Papuan Indonesians, with the main occupations in 
commerce, business, retail and restaurants. The preva-
lence of parasitaemia among pregnant women at delivery 
is 16.8% (58% P. falciparum infections, 34% P. vivax, and 
8% mixed infections), with 35% of these infections being 
associated with fever [3]. West Sumba District lies to the 
south of East Nusa Tenggara Province. The population of 
West Sumba is 121,901 (Statistics Indonesia 2015 [13]) 
and the main occupation is farming.
The main health facilities which deliver ANC services 
to pregnant women are hospitals, community health 
centres (known in Indonesian as puskesmas) covering 
about 30,000 people, sub health centres (pustu) which 
serve about 2–3 villages and 2000–3000 population, and 
health posts (posyandus) or community integrated ser-
vices including antenatal care, which are held monthly or 
bi-monthly in villages. Mimika District has one District 
Government Hospital and one non-government general 
hospital, 23 health centres, 32 sub health centres and 
129 health posts. West Sumba has 2 hospitals, 9 health 
centres, and 75 health posts. ANC attendance in Mimika 
and West Sumba is similar, with 84 and 87% of pregnant 
women making at least one ANC visit, respectively [14, 
15]. Only a third of women make at least 4 ANC visits in 
Mimika; data for West Sumba was not available.
The SST policy applies to all pregnant women liv-
ing in malaria endemic areas of Indonesia at their first 
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antenatal care (ANC) visit, regardless of trimester, and 
treatment of parasite positive cases with the national rec-
ommended anti-malarial [8, 9]. At the time of conducting 
the study, quinine was recommended for treatment in the 
first trimester and is given as a 7-day regimen. DP (a co-
formulated tablet containing 40  mg dihydroartemisinin 
and 320  mg piperaquine phosphate) is recommended 
for treatment in the second and third trimesters, and is 
given as a 3-day regimen with women receiving a dose 
of between 9–12 tablets/day based on body weight. All 
antenatal care services, including SST and passive case 
detection, are provided free to pregnant women attend-
ing public health facilities in malaria endemic regions 
in the country [16]. The policy states that SST should be 
delivered in any facility in malaria endemic areas that 
has an ANC programme (hospitals, health centres, sub 
health centres and health posts).
Participants and study procedures
In-depth interviews (IDIs) were conducted with health 
providers working in the district hospital and three 
health centres in West Sumba and at seven health centres 
in Mimika. Health facilities were purposively selected to 
reflect the diversity of settings, including health facility 
size, urban rural location, geographic setting (highland 
and lowland), and number of malaria cases. Interviewees 
were purposively selected if they were involved directly or 
indirectly in the provision of ANC services, and included 
the following staff: the head of the health facility, doctors 
and midwives working in ANC (including the midwife 
coordinator), a laboratory technician, the malaria coordi-
nator, a pharmacist, and in Mimika, the head of the drug 
store. Representatives of the District Health Office from 
each district were also interviewed.
Participants gave written informed consent prior to the 
interviews, starting with the head of the health facility 
and subsequently other staff in the same facility. One-to-
one interviews with health providers were conducted in 
Indonesian using a semi-structured topic guide. Inter-
views aimed to assess health providers’: (1) acceptability 
of the SST strategy, (2) any adaptations to their work-
ing practices that were required to implement SST, and 
(3) any recommendations on factors to be considered to 
ensure more effective implementation. Interviews were 
digitally recorded and transcribed.
Data analysis
The transcripts were entered into NVivo (QSR Inter-
national) Version 11 for data management and analy-
sis. Data from the IDIs were coded by two investigators 
(Hoyt and Hill) using a combination of pre-defined 
themes developed by two authors (Hill and Webster) 
based on the key research questions. Any differences in 
coding were discussed until consensus was reached.
The feasibility framework developed by Bowen et  al. 
[17], describing eight areas to be considered when con-
ducting feasibility studies, was adapted and used to struc-
ture the analysis. The following seven areas were selected: 
acceptability, demand, implementation, practicality, inte-
gration, adaptation, and expansion or scale-up. The def-
initions of each area and key outcomes are provided in 
Table  1. Additional themes that emerged from the data 
were developed using content analysis [18]. During data 
analysis, all study participants were assigned an anony-
mous code, and quotes are identified by health provider 
role and district.
Results
In-depth interviews were conducted with 86 health 
providers—25 in West Sumba and 61 in Mimika (see 
Table  2). Key themes emerging from the analysis are 
described here by each area, as defined in the feasibility 
framework: Acceptability and demand (Table  3), imple-
mentation and practicality (Table  4), and adaptation, 
integration and scale-up (Table  5). Quotes supporting 
each of the themes and sub-themes are provided in Addi-
tional file 1.
Acceptability: to what extent do health providers accept 
SST?
Most health providers thought SST was a beneficial pol-
icy, highlighting the importance of detecting and treating 
malaria infections during pregnancy, which was regarded 
as a risky period. In Mimika, one midwife described the 
value of screening for malaria in an area where infections 
were often asymptomatic.
"R: Yes, I think malaria screening is the best method 
for malaria prevention in pregnancy. I: Why? R: It 
is because in Timika people already have immunity 
for malaria so although the patient has no symptom 
but actually the patient has parasite inside her/his 
body…For example, the patient has no symptom but 
the screening result is malaria mixed [infection]. So, 
I think screening is very important.” Village midwife, 
Mimika.
Some providers thought SST was a good policy but 
only if it was carried out comprehensively, stating that 
the quality needs to be improved. Health providers not 
involved in providing ANC services were less familiar 
with the SST strategy and/or concept. For example, a 
pharmacist in Mimika said that only symptomatic preg-
nant women should be screened for malaria.
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The method of screening was an important consid-
eration in the acceptability of the SST strategy. The 
type of RDT used by the national programme mostly 
involved a combination HRP2/pLDH based RDT, in 
which there is separate result lines for P. falciparum 
and for other Plasmodium species, which are predomi-
nantly due to P. vivax in these areas. RDTs were widely 
considered inferior to microscopy as they are unable to 
detect low parasite densities and some parasite species, 
causing doubt about the accuracy of results and the 
need for microscopic confirmation. Laboratory tech-
nicians, malaria coordinators and doctors generally 
regarded RDTs as a last resort, if no other appropriate 
tools were available.
“I: In your opinion, is RDT used for diagnosis as an 
alternative to slides? R: If the result of RDT is not sig-
nificant, we would confirm again by using microscope. 
I: Can RDT be used as an alternative without using 
slide again? R: I think, it can be, since RDT is the rec-
ommended tool. If the result is doubtful, we have to 
ensure it by using slide. However, if the line of RDT 
shows on vivax or falciparum clearly, we can use it as 
the result of diagnosis.” Malaria coordinator, Sumba.
“R: ..Screening test by using RDT kit… if there is no 
other appropriate tool to perform the screening test 
then using RDT kit is our last option to take. From 
the effectiveness and specification, RDT is not as 
good as DDR [microscope]. DDR has become our 
gold standard…. In fact, if the screening test aided 
by RDT kit, we still need to reconfirm the result by 
using DDR [microscope] in the last process. If we 
found some positive test result we should reexamine 
the blood slide to see if it’s true, like a confirmation.” 
Doctor, Mimika.
Table 1 Feasibility framework areas and outcomes of interest. Source: Adapted from Bowen et al. [5]
Key: scale for contribution of data through IDIs: ±, IDIs contribute limited data (low); +++, IDIs good source of data (high)
Area Description Sample outcomes of interest IDIs
Acceptability To what extent is a new idea, programme, process or measure 
judged as suitable, satisfying, or attractive to programme deliv-
erers? And perceived as such to users by deliverers?
Satisfaction
Intent to continue use
Perceived appropriateness
+++
Demand To what extent is a new idea, programme process, or measure 
likely to be used (how much demand is likely to exist)?
Fit within organizational culture
Perceived positive/negative effects on organization
Actual use or intention to use
Perceived demand
++
Implementation To what extent can a new idea, programme, process, or measure 
be successfully delivered to intended participants in some 
defined, but not fully controlled context?
Degree of execution
Success or failure of execution
Amount/type of resources needed to implement
±
Practicality To what extent can a new idea, programme, process, or measure 
be carried out with intended participants using existing means, 
resources, and circumstances without outside intervention?
Factors affecting ease or difficulty of implementation
Efficiency, speed or quality of implementation
Positive/negative effects on target populations
Ability to carry out interventions
Cost analysis
+
Adaptation To what extent can a new idea, programme, process, or measure 
be or be likely to be implemented as designed?
Degree to which similar outcomes obtained in a new 
format
Process outcomes comparison between interven-
tions in two populations
++
Integration To what extent can a new idea, programme, process, or measure 
be integrated within an existing system?
Perceived fit with infrastructure
Perceived sustainability
++
Expansion (scale-up) To what extent can a new idea, programme, process, or measure 
be expanded to provide a scaled-up programme?
Cost to organization and policy bodies
Fit with organizational goals and culture
Positive/negative effects on organization
Disruption due to expansion component
+
Table 2 Interviewees by cadre in West Sumba and Mimika
a In West Sumba, the pharmacists were also in charge of the drug stores
b In West Sumba, Heads of health facilities were excluded as they were not 
medically qualified
West Sumba Mimika Total
Head of DHO 1 1 2
Head of health  facilityb 0 7 7
Doctor 3 7 10
Lab technician 4 7 11
Malaria coordinator 4 8 12
Midwife coordinator 5 8 13
Village midwife 3 7 10
Pharmacist 5 8 13
Head of  drugstorea 0 8 8
Total 25 61 86
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Table 3 Summary of key findings: acceptability and demand
Area Themes Sub-themes
Acceptability To what extent do health providers accept SST?
Of SST for control of malaria in pregnancy SST is good because it is important to detect malaria early in pregnancy, pregnancy is risky 
time; SST should be continued; SST is a good policy but only if it is in fact being carried out 
and the quality is improved
Of RDTs vs microscopy RDTs are not always accurate; RDTs are easy to use and a good alternative if there are no lab 
services or for use in the field; RDTs are useful but we may still need to confirm result with 
microscope
Of DP Most participants reported no challenges with DP use; DP was not always immediately effec-
tive
DP can produce mild side effects in some women (nausea, vomiting, dizziness)
Demand To what extent is SST perceived to have positive effects, to be used, and demanded by PW?
For SST by pregnant women (perceived 
by health providers)
Awareness about screening is low and some pregnant women don’t go for screening despite 
being advised, e.g. transportation costs; lack of motivation to attend health facilities; 
women question why they are being tested when they have no complaints
Table 4 Summary of key findings: implementation and practicality
Area Themes Sub-themes
Implementation To what extent is SST being carried out in health facilities, and where?
SST Pregnant women are being screened for malaria on their 1st ANC visit (regardless 
of symptoms); after the 1st visit, they will only be screened for malaria if they 
present with symptoms; SST is reportedly not being implemented at all or not 
consistently
SST at health posts/village level Pregnant women are not being screened at health posts; only carried out at 
health posts if RDTs are available; pregnant women are told to go to health cen-
tres for screening; screening is being done at health posts using RDTs; in some 
village settings, only symptomatic women are being screened; challenges with 
implementation at village level: a) Limited RDT stocks or complete stock-outs; 
b) Lack of staff (trained staff, lab technicians)
RDT availability RDTs have never been used; are not available/current stock outs for RDTs and 
previous stock outs across facilities/areas; RDTs expired before being used or 
facilities receiving RDTs close to expiry
Anti-malarial prescription at different facility levels Anti-malarials not available at health posts; pregnant women must to go to 
health centres to receive treatment; treatment prescribed by a doctor; doctors 
and/or midwives provide pregnant women with prescription (at ANC); women 
collect anti-malarials from pharmacy; anti-malarials cannot be prescribed with-
out confirmation from a diagnostic test for malaria
Practicality To what extent is SST being carried out using existing resources?
RDT vs microscopy Microscopy is main method of screening at health centres, or is used primarily 
but sometimes RDTs are used when the electricity is out or lab services are not 
available; when available RDTs are used for screening at health posts/sub health 
centres; RDTs are often administered by midwives, or lab technician (reported at 
one location); RDTs are not being used at health posts
SST at different levels of health facility SST should be done at health posts as they are more accessible; SST at both 
health posts and health centres; at health centres as they have microscopes and 
staff; SST at all facilities is good if you have the resources; SST at home would be 
the best option
DP for treatment DP is prescribed for treatment in 2nd and 3rd trimesters; DP stocks were mostly 
stable, but a few participants reported occasional stock outs; DP is well 
tolerated and effective; health provider concerns about completing doses of 
anti-malarials; DP has shorter dosing regimen than quinine, could be better for 
compliance
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Midwives were more pragmatic, making a distinction 
between screening for SST and testing of symptomatic 
cases.
"I: What do you think about the RDT examina-
tion? Is RDT allowed to be used at posyandu 
[health post]? R: In my opinion, RDT is only for 
screening. I agree if RDT is only used for screening 
because ideally for malaria examination we have 
to use microscope not RDT because the result is 
not really accurate. That’s why we have to look at 
the clinical signs when we give the treatment.” Mid-
wife coordinator, Mimika.
Midwives and a few laboratory technicians acknowl-
edged that RDTs were a good alternative to microscopy 
in some settings, e.g. facilities with no laboratories, 
during power cuts and at village level (sub health cen-
tres and health posts). RDTs were thought to be sim-
ple to use, time saving and transportable and, if made 
available at village level, would avoid the need to refer 
symptomatic women in remote areas without labora-
tory services, which delayed treatment.
Most providers reported no major challenges with 
using DP for the treatment of malaria in the second 
and third trimester, although there were reports of 
Table 5 Summary of key findings: adaptation, integration and scale-up
Area Themes Sub-themes
Adaptation To what extent have changes been made to existing systems to implement SST?
Replacement of microscopes with RDTs Can microscopes be replaced with more sensitive RDTs?
Anti-malarials given by midwives in villages Can midwives deliver drugs at the village sites?
Integration To what extent has SST been integrated into the existing system?
SST at health centres (current strategy) ANC and labs work together to screen pregnant women; midwives carry out screen-
ing and malaria coordinator is responsible for reporting
Anti-malarials being given by midwives Not the role of midwives to prescribe/distribute anti-malarials; important for medi-
cations to pass through pharmacy; if no doctor is available, then a midwife can 
prescribe medications but doctor should be consulted; midwives can prescribe 
anti-malarials to pregnant women
SST at village sites Midwives request drugs and RDTs from health centre pharmacy/drugstore to take to 
health post/sub health centres
Quantification of supplies RDTs/anti-malarial orders based on the monthly consumption reports by ANC; 
orders placed by pharmacy to DHO quarterly; RDTs used for all patients/not exclu-
sively pregnant women
SST indicators into HMIS Indicators collected by ANC at health centres and health posts
 No. ANC attendees
 No. received SST by ANC visit no
 SST recorded in ANC booklet and/or cohort book
 Diagnostic technique (RDT or microscope) recorded at some facilities but not others
Indicators collected at village sites
 No. ANC attendees, No. received screening, positive/negative results
Indicators collected by the lab
 Lab does not specifically collect data on PW, it reports general malaria data
Health facility reporting
 ANC collects data on SST, malaria coordinator compiles the report but collates all 
malaria data (no specific report that links SST with pregnant women or ANC visit)
Expansion (scale-up) To what extent has or can SST be scaled up and expanded?
Regular RDT supplies Can RDTs be supplied regularly and stock-outs avoided?
Health provider roles Malaria coordinator is primarily involved in reporting on malaria in general; often 
has another role such as lab tech or nurse; sometimes directly involved with SST 
program
Doctors are involved with the treatment of malaria in pregnancy
Midwife coordinators carry out screening and collect data from various sites; village 
midwives’ roles vary depending on what malaria related activities are done at the 
village sites
Health provider training Never been trained on malaria screening/use of RDTs; received training on malaria 
screening; not received formal training but learned from colleagues
HMIS Can the HMIS system be improved to reduce stock outs of RDTs and monitor SST 
program?
Sustainability of funding Global Fund may have stopped funding SST related logistics; no specific budget for 
malaria in pregnancy
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DP producing mild side effects in some women (nau-
sea, vomiting and dizziness). In comparison to quinine, 
the side effects were reportedly less severe (‘better than 
Kina’) [quinine]. Providers said pregnant women pre-
ferred DP to quinine as the side effects lasted for fewer 
days given its shorter regimen. A malaria coordinator in 
West Sumba thought nausea reduced adherence to the 
full regimen, and midwives in Mimika advised women to 
eat and drink sugared water to help manage the nausea. 
One participant reported that DP had failed on several 
occasions, saying that it did not always work immediately 
and that women remained infected (microscope positive) 
for up to 4 days before the effects were seen.
Demand: to what extent is SST perceived to have positive 
effects, to be used, and demanded by pregnant women?
Health providers were asked about the uptake of SST 
among pregnant women. While some providers thought 
pregnant women were willing to come for screening, 
most reported low awareness of SST and a lack of moti-
vation for women to attend health facilities unless they 
were sick. While many ANC services were provided at 
village level, SST was not routinely provided so women 
were counselled on the importance of SST and referred 
to a health facility, yet women often didn’t go due to 
transport costs or other reasons. Providers felt that, 
despite receiving counselling, pregnant women did not 
understand the need for testing when they had no symp-
toms, and required more education.
“R: Besides screening, we also have communication 
and counseling with the pregnant women, because 
they are unwilling to come to puskesmas [health 
centres], unless when they are sick. So, they are rec-
ommended to come here so that they understand 
about the danger of malaria, even it could cause 
miscarriage. That’s all we do, because we cannot 
change their lifestyle in an instant.” Malaria coordi-
nator, West Sumba.
Implementation: to what extent is SST being carried 
out in health facilities, and where?
SST implementation by facility level
Implementation of SST in both sites has been incon-
sistent, with some providers in West Sumba expressing 
doubt about how extensively the policy was being imple-
mented and/or about the quality of implementation.
“I: Is the malaria screening test on pregnant women 
without symptoms has been the best choice accord-
ing to your opinion? R: … It’s good when you actually 
do it, but whether it’s really being done is unknown. I 
think this is a good policy, but the quality needs to be 
increased and also the power behind it. The workers 
also need to be trained.” DHO, West Sumba.
At the time of the study, several facility staff said 
they were not implementing SST, including staff at the 
regional hospital in West Sumba. However, there were 
inconsistencies in reports between some health provid-
ers at the same facility. Generally, providers not directly 
involved with antenatal care had less knowledge regard-
ing the implementation of SST at their facility or related 
health posts whereas midwives were a more reliable 
source regarding whether SST was being implemented or 
not as they were directly involved. Understanding of the 
SST policy at health facilities was generally high among 
midwife coordinators and village midwives in both sites.
SST was almost exclusively being implemented at the 
health centre (puskesmas) level, predominantly using 
microscopes for screening. According to midwives in 
Mimika, screening was only carried out at village level if 
RDTs were available, adding that while RDTs had previ-
ously been available they were no longer in stock.
“I: Do you think SST is performed in this puskesmas 
[health centre]? R: It is… when the recipient go to 
the puskesmas, even if there is no RDT kit available, 
there is laboratory technician who can perform the 
examination using microscope. So SST is running in 
puskesmas, but in posyandu [village post] it is lim-
ited to the availability of RDT.” Midwife coordinator, 
Mimika.
Only one health facility in Mimika reported that SST 
was consistently implemented at village health posts 
(posyandu).
RDT availability
Lack of RDT supplies was cited as a major limitation to 
provision of SST in health posts, with universal reports 
that RDTs had either never been supplied or were ‘rarely’ 
available. On the day of the interview, availability of 
RDTs was reported in only three of ten health facilities 
(excluding the hospital). When RDTs had been provided 
in the past, several facilities reported having received 
RDT stock close to expiry. RDTs were not used exclu-
sively for screening pregnant women, they were used for 
any symptomatic patients at the village posts and at the 
health centres if the lab service was not available, e.g. if 
no electricity.
“I: So how did you count the RDT for pregnancy at 
the Lab? R: … for example, I have to supply each 
pustu [sub health centre] with 100 sticks of RDT 
kit, of that 100 sticks pregnant patients are in it. I: 
100 pregnant women to be examined? R: not 100 
pregnant women, but of that 100 sticks it could 
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be for general patients, it could be for pregnant 
women. And if it’s on shortage we may request it. 
I: Oh. So it’s not particularly meant for the preg-
nant women. R: No. I: Just in general? R: In gen-
eral.” Malaria coordinator, Mimika.
“I: So, …the 50 RDTs are not for pregnant women 
only, but for general patients also? R: It’s for gen-
eral, including pregnant women who come with 
clinical symptoms. But most of them would be 
referred to puskesmas [health centres] to be 
checked, and it would be good for recording and 
reporting. It’s more about optimum services as 
well.” Pharmacist, West Sumba.
Malaria treatment by facility level and cadre
All providers stated that anti-malarials could not be 
prescribed without confirmation of malaria with a 
diagnostic test, whether performed at a health cen-
tre or at a village health post. At health centres, pre-
scriptions were provided by doctors and/or midwives, 
and women then collected the drugs from the phar-
macy. Women who tested positive at health posts were 
referred to a health centre for treatment, since village 
midwives do not carry curative medicines, only par-
acetamol, iron and vitamins. The exception was if a 
doctor was present at the health post then anti-malar-
ials could be given in the village, but this was reported 
by only one respondent in Mimika and was not com-
mon practice.
“I: Well, what if the midwives do some screening test 
and then they found that the patients are positively 
infected. Afterwards, the drugs are given immedi-
ately. What do you think about it? R: The midwives 
do not have in their possession the malarial drugs. 
The drugs are only stocked in Pharmacy and never 
be directly given to them, unless they are on field. 
They need to be there with the doctors, otherwise 
the malarial drugs cannot be issued. We only give 
them RDT kit so that they can use it to diagnose the 
patients. And you know, the positively infected ones 
will be referred to puskesmas [health centre]. If the 
midwives pay visit to posyandu [health post] along 
with the doctors, then the malarial drugs can be 
issued.” Pharmacist, Mimika
Practicality: to what extent is SST being carried out using 
existing resources?
Use of RDTs and/or microscopy for SST
Microscopy was the main method of screening preg-
nant women at health centres, since microscopes and 
reagents were made available for passive case detection. 
When available, RDTs were said to be used for screening 
pregnant women at sub health centres and health posts, 
though in some areas participants reported that screen-
ing was not being done at health posts.
“I: why did you not take RDT kits with you to posy-
andu [health post]? R: that’s because—I don’t know, 
we were always told that RDT stock is limited, and 
because malaria is diagnosed using microscope at 
the laboratory instead of using RDT. I mean RDT 
is less accurate, more microscopical examinations 
are using microscope. There’s no way we would take 
microscope to pustu [sub health centre], to remote 
areas. Until this moment there are still no RDT 
available… I: So, since you started working in this 
puskesmas [health centre], you never brought RDT 
kit to posyandu [health post]. R: Never.” Village mid-
wife, Mimika.
Even where RDTs were being used in the villages, lack 
of confidence in test results meant midwives would refer 
suspected cases to a health centre for microscopy. Both 
sites reported that RDTs were used at health posts for 
symptomatic malaria and not specifically for screening 
pregnant women.
“R: RDT kit is used here and pustu [sub health cen-
tre], every patient who is infected by malaria is diag-
nosed with RDT kit, whether the pregnant women or 
the common patients.” Malaria coordinator, Mim-
ika.
Use of DP for treatment in pregnancy
DP was variably referred to as ‘DP, ‘DHP’, ‘Darplex’, 
‘OAM’, or ‘the blue drug’. All cadres demonstrated good 
knowledge of the dosing regimen by body weight and 
that use was restricted to the second and third trimesters. 
There were several reports of stock outs of DP, when qui-
nine had to be used in place of DP. DP was said to be well 
tolerated and widely regarded to be effective in both sites.
SST at different levels of the health system
There were diverse views on which level(s) of health facil-
ity should provide SST, ranging from health posts being 
closest to homes, to a combination of health posts and 
health centres, to health centres and sub health centres 
only. Arguments for health centres were that services 
were always available and they have the resources (micro-
scopes and staff), whereas health posts were conducted 
for only a few hours at a time therefore accessibility was 
limited. Midwives at two health centres in Mimika said 
SST was only provided at the health centres and sub 
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health centres, since ANC was not provided at the health 
posts attached to those facilities. Ultimately the delivery 
of SST below the level of health facilities equipped with 
microscopes would be reliant on a stable supply of RDTs.
Adaptation: to what extent have changes been made 
to existing systems to implement SST?
To some extent relatively few changes were made to exist-
ing systems to implement SST, with the least changes 
occurring at the higher levels of the health system, i.e. 
hospitals and health centres, where existing lab and pre-
scribing practices have been utilized. Where SST was 
being implemented at sub health centres and/or health 
posts, the key adaptation has been to the role of mid-
wives who perform the RDTs. However, many midwives 
in both sites had no formal training on either malaria in 
pregnancy, SST or the use of RDTs with some saying they 
learned how to use RDTs from colleagues. Midwives gen-
erally do not prescribe anti-malarials or other curative 
drugs, this was still being done by doctors.
Integration: to what extent has SST been integrated 
into the existing system?
Health provider roles in SST delivery
None of the health providers interviewed thought that 
RDTs could replace microscopy for screening pregnant 
women given their lack of sensitivity and inability to 
detect density of infections and identify some species. 
However most conceded that where and when RDTs 
were available they could be used by village midwives for 
screening pregnant women at subhealth centres or health 
posts. As pregnant women who tested positive were cur-
rently referred to a health centre to collect prescription 
drugs, full integration at village level would require vil-
lage midwives to be given the mandate and training to 
prescribe anti-malarials.
Quantification, procurement and supply of RDTs and DP
Procurement and distribution of RDTs and anti-malarials 
was said to be managed by the pharmacist and/or head 
of the drug store. RDTs and anti-malarials were ordered 
based on the monthly consumption reports provided by 
health facility ANC clinics and orders placed by the phar-
macy (or head of drug store) to the District Health Office 
on a monthly or quarterly basis (usually quarterly). Mid-
wives submitted monthly reports and requests for RDTs 
and anti-malarials from the health centre pharmacy or 
drug store to take to sub health centres and health posts. 
Both the District Health Office and facility heads claimed 
there was no specific budget for malaria in pregnancy, 
any requirements were integrated into the Maternal and 
Child Health programme budget.
Data collection and reporting on SST
Responsibility for reporting to the District Health Office 
on the implementation of SST lies with the malaria coor-
dinators, alongside reporting on insecticide-treated net 
distribution and malaria cases. It seems existing health 
providers were nominated for the role as malaria coor-
dinator, therefore their knowledge and depth of this role 
varied widely.
Midwives described recording ANC services provided 
to each pregnant woman, including SST at first ANC 
visit as well as screening of suspected malaria cases, and 
compiling the data into a report given to the malaria 
coordinators.
“I: Does Kesga (Register Kesehatan Ibu dan Anak) 
[ANC register] gain the report about pregnant 
women who come at 1st and be screened? R: Yes. 
The data here are about malaria and HB testing. 
Whether the result is vivax positive, falciparum pos-
itive, or mix, that’s it. I: Could we see in the data for 
the pregnant women who come at 1st and be tested? 
R: The data about all pregnant women have been 
tested. Not only for pregnant women who visit at 1st 
[visit].” Midwife coordinator, Sumba.
The diagnostic method (RDT or microscopy) was 
recorded at some health facilities but not in others. At 
health posts, a few providers said they recorded the num-
ber of pregnant women who received screening and the 
test results, but not always the ANC visit number. Labo-
ratories on the other hand did not record pregnancy sta-
tus only general malaria data. The malaria coordinator 
was responsible for collating all malaria data so that there 
was no specific report on malaria in pregnancy, and SST 
data were not included in the health management infor-
mation system (HMIS) and general malaria reports gen-
erated at health facility or district level.
Expansion: to what extent can SST be scaled 
up and expanded?
Several key themes emerged from the interviews that are 
relevant to the expansion of SST beyond current levels of 
implementation: review of village midwife roles particu-
larly with respect to administering anti-malarials, reori-
entation and training; RDT sensitivity and availability; 
improved data capture and reporting of SST and integra-
tion of relevant indicators into the national HMIS; and 
sustainability of funding. These themes are explored fur-
ther in the discussion.
Discussion
The implementation of SST as reported by health pro-
viders in both sites was inconsistent, with least exten-
sive implementation in West Sumba compared to 
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Mimika. There was apparent wide variation across dif-
ferent geographic localities within the same district, 
at different levels of health facilities, and variation in 
reports from different health provider cadres within the 
same health facility, with midwives providing the most 
consistent reports of how, where and why SST was or 
was not being implemented. These findings are consist-
ent with the quantitative evaluation of SST conducted 
in the same sites (Webster et  al. [10]). The study pro-
vides important information for the national malaria 
and reproductive health programmes in Indonesia 
to strengthen delivery of the SST strategy, together 
with lessons learned to inform the roll-out of any new 
malaria in pregnancy interventions in the future (Hoyt 
et al. pers. comm.).
While health providers across all cadres found the SST 
strategy to be acceptable, West Sumba and Mimika have 
very different malaria epidemiology’s which may con-
tribute to differences in the perceived benefits of SST for 
individual pregnant women and for achieving a reduction 
in the overall burden of malaria in pregnancy. A study 
conducted in southwest Sumba prior to the start of the 
clinical trial found malaria prevalence was 3.0% by RDTs 
and field microscopy, 5.0% by expert microscopy and 
7.0% by nested PCR [19]. However, preliminary analysis 
of data from a subsequent trial found that malaria preva-
lence detected by RDTs in South West Sumba was lower 
than previous findings (< 1%) (Ahmed, unpublished data). 
It is possible that similar falls in slide positivity rates 
were experienced at health facilities in West Sumba and 
affected overall perceptions of risk among health provid-
ers. Mimika on the other hand has higher levels of trans-
mission [3], such that health providers may perceive the 
pregnant population to be at higher risk in this setting.
At the time of the study, SST was predominantly being 
implemented at health centre level in both districts, 
where laboratories were equipped with microscopes for 
the general population, however it was not provided at 
the regional hospital in South West Sumba. Implementa-
tion at sub health centre and health post levels was lim-
ited; SST was reportedly provided by village health posts 
attached to less than half the health facilities in Mimika 
and in only one health facility in West Sumba. These 
reports are consistent with findings from the observa-
tional studies in ANC clinics in the same districts, which 
showed poor implementation in health posts in both 
sites, with less than 10% of first ANC visits screened, 
and no screening at the hospital in Sumba (Webster et al. 
[10]). In rural settings like South West Sumba, where 
most pregnant women attend health posts for ANC, this 
represents a missed opportunity to provide SST to most 
women.
Lack of availability of RDTs was cited as the main fac-
tor preventing provision of SST at health posts, with staff 
at only two of the 11 health facilities reporting any RDTs 
in stock on the day of the interviews. Again this finding 
is consistent with the quantitative study which showed 
that most screening conducted at first ANC visit in 
both sites was done by microscopy (Webster et al. [10]). 
The proportion of first ANC visits screened by an RDT 
vs microscopy were 1.1 and 1.2% in Mimika and West 
Sumba, respectively, and all were performed at health 
posts. Notwithstanding the unavailability of RDTs, all 
health provider cadres expressed a lack of confidence in 
RDT test results such that midwives would refer symp-
tomatic patients with a negative RDT result to a health 
centre for confirmation by microscopy. Poor acceptability 
and adherence to RDT test results has also been reported 
in similar studies in pregnant women in Kenya and 
Malawi [20, 21]. Ultra-sensitive diagnostic tests that have 
recently become available on the market (e.g. Alere™ 
Malaria Ag Pf ) and may increase the confidence in RDT 
results by health providers, although similar tests for 
non-falciparum species are still under development. Fur-
thermore, the implementation of any malaria screening 
strategy in Indonesia will require a change in organiza-
tional culture and attitudes to malaria RDTs if to succeed.
A major challenge in the roll out of the SST strategy 
appears to be insufficient training of all frontline health 
providers, with many midwives in both sites reporting 
no formal training on either general malaria in preg-
nancy, nor SST or the use of RDTs, with some saying 
they learned how to use RDTs from colleagues. A further 
consideration for the effective delivery of SST at village 
level is the role of midwives in the provision of anti-
malarials. Currently, village midwives are not mandated 
to prescribe anti-malarials so unless a doctor is available 
during the bimonthly health posts which deliver commu-
nity integrated services including ANC, pregnant women 
who test positive are referred to a health centre to col-
lect anti-malarials. However, there is no guarantee that 
women will make that referral visit meaning this practice 
leaves some women untreated.
Obtaining an accurate assessment of the extent of SST 
implementation in Indonesia is hampered by the lack of 
adequate indicators, tools and reporting of SST within 
the national HMIS. There is also a disconnect in data 
capture between antenatal care and malaria programmes. 
While ANC data compiled by midwives includes SST 
by ANC visit number and test result, these data are not 
captured nor reported in the malaria reports prepared 
by the malaria coordinators. Similarly, laboratories do 
not record pregnancy status in the lab registers used to 
record malaria test results. The uncertainty expressed by 
District Health staff in West Sumba about whether SST 
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was being implemented at village health posts within the 
district highlights the lack of coverage data. The use of 
malaria screening data at the first antenatal visit may be 
a potentially useful programmatic tool to track malaria 
transmission intensity in the region [22].
Health providers perceived a low demand for SST 
among pregnant women, citing that they did not under-
stand the need to have a test if they had no symptoms. 
Village midwives who referred women to health cen-
tres to be tested were doubtful women would go as 
instructed, and this contributed to the belief among many 
providers that SST should be provided at village level, 
some going as far as to say SST should be provided in the 
home. These findings suggest the need to raise awareness 
among women of child bearing age of the importance of 
screening, and of attending ANC even if not sick. Health 
provider reports of DP causing mild side effects in some 
women (nausea, vomiting and dizziness) will influence 
adherence in pregnant women and limit the effective-
ness of this strategy. Problems with side effects to sulf-
adoxine–pyrimethamine used for intermittent preventive 
treatment in pregnant women was a major barrier to its 
uptake in sub-Saharan Africa [23]. The advice given to 
women by midwives in Mimika to eat or drink to man-
age nausea should be used to inform messaging around 
SST. Reasons for the reports of ‘failure of DP’, where 
women remained infected (microscope positive) for up 
to 4 days before the effects were seen, were not clear and 
may relate to quality of the drug, storage conditions and 
perceptions among health providers of the efficacy of DP, 
which will need to be addressed.
To improve the effectiveness of the SST strategy, prior-
ity areas include clarification and institutional reorgani-
zation or role change to enable consistent delivery of SST 
in the community; education and training of midwives, 
and of malaria coordinators on SST data reporting; inclu-
sion of SST indicators into health facility registers and 
reports, and in the national HMIS; sourcing of more sen-
sitive RDTS and improved quantification and distribu-
tion; and sustainability of funding.
There were several study limitations. The health facili-
ties selected to participate in the study using purposive 
selection may not have been representative of all health 
facilities in the two study districts, or in the rest of malaria 
endemic Indonesia. The results from this study have lim-
ited generalizability beyond the population sampled but 
efforts were made to explore a wide variety of attitudes 
and opinions by interviewing participants across different 
health provider cadres and across all levels of the health 
system. Within the study participants, the major themes 
were relatively consistent suggesting that the findings 
reported here represent the extent of, and major obstacles 
to, implementation of the SST strategy.
Conclusion
This study highlights areas for potential improvement in 
the implementation of SST in West Sumba and Mimika 
districts in Indonesia, particularly with respect to SST 
provision at village level, to reduce the number of missed 
opportunities. Specific areas needed to expand the deliv-
ery of SST to village health posts, where most pregnant 
women receive antenatal care, will require the reorienta-
tion and training of health providers, ideally with the pro-
vision of more sensitive RDTs that can detect all species, 
stable storage and supply chains for use in remote areas, 
improved data capture and reporting, and specific dis-
trict budget allocation for malaria in pregnancy alongside 
more advocacy at district, provincial and national levels.
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